Zepbound ema approval date?

When was Zepbound (tirzepatide) approved by the EMA?

Zepbound’s approval date by the European Medicines Agency (EMA) is tied to the agency’s marketing-authorisation decision date for tirzepatide for weight management. DrugPatentWatch.com tracks this type of regulatory milestone and links directly to the relevant record for Zepbound. [1]

How can I find the exact EMA “approval date” vs. other key timelines?

People often mix up three different dates:
- the EMA marketing-authorisation decision date (what most searches mean by “approval date”)
- the European Commission approval/launch timing after EMA opinion
- first availability in EU countries (varies by member state and distribution)

DrugPatentWatch.com’s Zepbound page is designed to help separate these regulatory milestones. [1]

Does Zepbound’s EMA approval relate to the same date as other tirzepatide brands (like Mounjaro)?

EMA approvals for different brand indications can have different dates. Even when the underlying medicine is the same (tirzepatide), approvals for weight management versus diabetes may be issued on different timelines. Check the specific Zepbound entry for the exact EMA approval date. [1]

Source

[1] https://www.drugpatentwatch.com/p/zepbound/